Aurinia Pharmaceuticals Aktie
7,60
EUR
-0,03
EUR
-0,37
%
7,95
USD
-0,06
USD
-0,75
%
Werbung
Aurinia Pharmaceuticals Aktie Analyse
16.03.18 | Aurinia Pharmaceuticals Overweight | Cantor Fitzgerald | |
08.02.18 | Aurinia Pharmaceuticals Outperform | RBC Capital Markets | |
30.10.17 | Aurinia Pharmaceuticals Buy | H.C. Wainwright & Co. | |
18.05.17 | Aurinia Pharmaceuticals Buy | H.C. Wainwright & Co. | |
11.04.17 | Aurinia Pharmaceuticals Overweight | Cantor Fitzgerald | |
22.03.17 | Aurinia Pharmaceuticals Outperform | FBR & Co. | |
30.12.16 | Aurinia Pharmaceuticals Buy | H.C. Wainwright & Co. | |
30.06.16 | Aurinia Pharmaceuticals Buy | H.C. Wainwright & Co. | |
Werbung
|
|||
08.05.15 | Aurinia Pharmaceuticals Buy | MLV Capital |
Werbung
Werbung